Published in Br J Ophthalmol on October 01, 2003
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness. Br J Ophthalmol (2007) 3.08
Consequences of amblyopia on education, occupation, and long term vision loss. Br J Ophthalmol (2004) 1.42
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial. Br J Ophthalmol (2012) 1.01
A revolution in Welsh low vision service provision. Br J Ophthalmol (2005) 0.84
Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension. Arch Ophthalmol (2010) 0.81
Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the United Kingdom? J Health Serv Res Policy (2013) 0.78
Recent trends in visual impairment and blindness in the UK. Arch Dis Child (2007) 0.78
Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom. Diabetes Ther (2017) 0.77
More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England. BMC Health Serv Res (2016) 0.76
The prevalence and causes of visual impairment in young Turkish men. Pak J Med Sci (2015) 0.75
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. J Mark Access Health Policy (2016) 0.75
The calculation and use of economic burden data. Br J Ophthalmol (2006) 0.75
The Cost of Blindness in the Republic of Ireland 2010-2020. J Ophthalmol (2016) 0.75
Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: an economic evaluation based on data from the EAGLE trial. BMJ Open (2017) 0.75
Projected Long-Term Outcomes in Patients With Type 1 Diabetes Treated With Fast-Acting Insulin Aspart Versus Conventional Insulin Aspart in the Uk Setting. Diabetes Obes Metab (2017) 0.75
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK. Diabetes Ther (2017) 0.75
Diabetic retinopathy in the West of Scotland: its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bull (Edinb) (1983) 4.95
The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med (1995) 4.03
The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology (2001) 3.04
Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med (1996) 2.46
Minimising the impact of visual impairment. Low vision aids are a simple way of alleviating impairment. BMJ (1999) 2.44
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care (1994) 2.30
Helping blind and partially sighted people to read: the effectiveness of low vision aids. Br J Ophthalmol (2000) 1.57
Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care (1991) 1.51
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Prevalence of low vision in elderly patients admitted to an acute geriatric unit in Liverpool: elderly people who fall are more likely to have low vision. Gerontology (1995) 1.42
Visual impairment and eye diseases in elderly institutionalized Australians. Ophthalmology (2000) 1.22
Direct costs of blindness in Australia. Clin Experiment Ophthalmol (2000) 1.14
Emotional distress in patients with retinal disease. Am J Ophthalmol (2001) 1.06
Federal budgetary costs of blindness. Milbank Q (1992) 1.04
Unrecognized visual problems amongst residents of Part III Homes. Age Ageing (1994) 0.88
Community mental health care for former hospital in-patients. Predicting costs from needs and diagnoses. Br J Psychiatry Suppl (1995) 0.87
Development of a shorter version of the geriatric depression scale for visually impaired older patients. Int Psychogeriatr (2000) 0.85
Loneliness, depression, and social activity after determination of legal blindness. Psychol Rep (1983) 0.84
Cost of care for patients with age-related macular degeneration in Switzerland and cost-effectiveness of treatment with verteporfin therapy. Semin Ophthalmol (2001) 0.82
The cost of depression in the elderly. Effects of drug therapy. Drugs Aging (1997) 0.81
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut (2008) 3.65
The value of feedback in teaching interviewing skills to medical students. Psychol Med (1978) 3.24
Teaching critical appraisal skills in health care settings. Cochrane Database Syst Rev (2001) 2.57
Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (2006) 2.06
Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Br J Psychiatry (1978) 2.03
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
Barriers to help seeking in people with urinary symptoms. Fam Pract (2001) 1.81
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (2007) 1.72
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev (2007) 1.68
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (2005) 1.47
Riluzole for motor neurone disease. More trials are needed. BMJ (2001) 1.47
The type and quality of randomized controlled trials (RCTs) published in UK public health journals. J Public Health Med (1995) 1.46
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess (2012) 1.28
Emphysematous cystitis and pyelitis in a diabetic renal transplant recipient. Transplantation (1996) 1.26
Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess (2000) 1.24
A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem (1994) 1.22
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess (2007) 1.19
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol (2005) 1.17
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technol Assess (2010) 1.15
The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess (2001) 1.13
Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev (2004) 1.05
The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technol Assess (2005) 1.03
Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. Health Technol Assess (2005) 0.99
Who uses the Cochrane Pregnancy and Childbirth Database? BMJ (1995) 0.98
Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br J Surg (2002) 0.95
Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Health Technol Assess (2010) 0.95
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess (2000) 0.94
Critical appraisal workshops to promote evidence-based healthcare. J Obstet Gynaecol (2000) 0.92
Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy (2000) 0.90
Clinical correlates of high-intensity transient signals detected on transcranial Doppler sonography in patients with cerebrovascular disease. Stroke (1994) 0.86
Effect of time and cerebrovascular symptoms of the prevalence of microembolic signals in patients with cervical carotid stenosis. Stroke (1996) 0.85
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Health Technol Assess (2009) 0.84
A male MZ twin pair, concordant for transsexualism, discordant for schizophrenia. Acta Psychiatr Scand (1977) 0.84
An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technol Assess (2011) 0.82
Amino acid structure and "difficult sequences" in solid phase peptide synthesis. Int J Pept Protein Res (1993) 0.82
Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review. Br J Ophthalmol (2004) 0.82
Improvement in HDL cholesterol in postmenopausal women supplemented with pumpkin seed oil: pilot study. Climacteric (2011) 0.81
Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health Technol Assess (2010) 0.81
Infliximab for the treatment of acute exacerbations of ulcerative colitis. Health Technol Assess (2010) 0.80
Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema. Thorax (1999) 0.80
Cerebral microembolism and early recurrent cerebral or retinal ischemic events. Stroke (1997) 0.79
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia. Cochrane Database Syst Rev (2005) 0.79
The SF-36: an instrument for measuring quality of life in ESRD patients. EDTNA ERCA J (2002) 0.79
Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technol Assess (2002) 0.79
Heterogeneous luteinizing hormone and follicle-stimulating hormone storage patterns in subtypes of gonadotropes separated by centrifugal elutriation. Endocrinology (1983) 0.78
Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia. Health Technol Assess (2010) 0.78
Adrenal hemangioma: an unusual adrenal mass delineated with magnetic resonance imaging. J Urol (1991) 0.78
Cerebral microembolism in patients with retinal ischemia. Stroke (1998) 0.77
Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK. Health Technol Assess (2011) 0.76
Morphometric analysis of thyrotropes in developing and cycling female rats: studies of intact pituitaries and cell fractions separated by centrifugal elutriation. Endocrinology (1983) 0.76
Collaboration with the Campbell collaboration. The Campbell principles are applied in West Midlands through public health research forum. BMJ (2001) 0.75
The significance of early postoperative duplex studies following carotid endarterectomy. Cardiovasc Surg (1999) 0.75
Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation. Health Technol Assess (2002) 0.75
Identification and assessment of ongoing trials in health technology assessment reviews. Health Technol Assess (2004) 0.75
Quality of life research: a valuable tool for nephrology nurses. J Ren Care (2007) 0.75
Probing the high momentum component of the deuteron at high Q2. Phys Rev Lett (2011) 0.75
Nephrology nursing practice: more than technical expertise. EDTNA ERCA J (2000) 0.75
The computer age impacts nurses. Comput Nurs (1997) 0.75
Diagnosis of intracranial injury. Lancet (1997) 0.75
Correlation of transcranial Doppler and noninvasive tests with angiography in the evaluation of extracranial carotid disease. J Vasc Surg (1990) 0.75
Douglas House: a new type of hostel ward for chronic psychotic patients. Br J Psychiatry (1985) 0.75
Establishing nephrology nursing specialization in Japan: a matter of urgency. EDTNA ERCA J (2005) 0.75
Oestrogen and testosterone implants. Aust N Z J Obstet Gynaecol (1994) 0.75
Control of populations by infection. Australas Nurses J (1976) 0.75
Digital transmission of physiological data. Biomed Sci Instrum (1972) 0.75
Labelling and drug effects in the treatment of neurotic affective disorders: an experimental investigation. Psychol Med (1983) 0.75
Recent advances in the design and performance of research assistants. Redox Rep (2001) 0.75
Shortcomings of protein removal prior to high performance liquid chromatographic analysis-A case study using method development for BAY 11-7082. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75